Stephen J. Hoffman
Direktor/Vorstandsmitglied bei RESEARCH ALLIANCE CORP. II
Vermögen: 2 708 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Stephen J. Hoffman
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 43 | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO.
37
| Subsidiary | Pharmaceuticals: Major | 37 |
| Public Company | Pharmaceuticals: Major | 30 | |
Sirtris Pharmaceuticals, Inc.
 Sirtris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sirtris Pharmaceuticals, Inc., a GSK company, is developing small molecule drugs that target the sirtuins, a family of seven enzymes associated with diseases of aging. Modulation of these enzymes offers the promise of drug discovery in multiple therapeutic areas. Sirtris was one of the pharmaceutical companies focused on the sirtuin platform and remains the innovative drug discovery. Preclinical research indicates that the sirtuins play important roles in pathways for multiple diseases of aging, including Type 2 Diabetes, as well as neurodegenerative, cardiovascular and inflammatory diseases. Sirtris researchers are working to translate this research into a potential new class of pharmaceuticals to treat diseases of aging, offering the ability for people to live longer, healthier lives. Sirtris has focused on developing many novel small molecule activators of SIRT1, the most studied member of the sirtuin family. These new chemical entities or NCEs are novel compounds that are chemically unrelated to resveratrol, a naturally occurring compound that was used as an early proof-of-concept for SIRT1 activation. Besides being structurally differentiated from resveratrol, the NCEs are more specific for the target SIRT1 and have improved drug-like properties. The company has completed several early stage translational clinical studies with the first generation NCEs and has several active clinical trials under way. Sirtris operates as an independent Discovery Performance Unit (DPU) within GSK and is located in Technology Square, Cambridge, Mass. Sirtris' culture mixes scientific curiosity with a dynamic, fast-paced environment, resembling its biotech roots while harnessing all of GSK's broad discovery, development, and commercialization capabilities. The company was founded in 2004 and is headquartered in Cambridge, MA.
25
| Extinct | Pharmaceuticals: Major | 25 |
| Public Company | Biotechnology | 21 | |
| Public Company | Medical Specialties | 18 | |
| Public Company | Biotechnology | 13 | |
Danforth Advisors LLC
 Danforth Advisors LLC Investment ManagersFinance Danforth Advisors LLC provides advisory services. It offers finance support and stratigic consultation services for life science firm. The company was founded by Gregg Beloff and Daniel Geffken and is headquartered in Southborough, MA.
9
| Holding Company | Investment Managers | 9 |
Receptor Life Sciences, Inc.
 Receptor Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Receptor Life Sciences, Inc. operates as a pharmaceutical development company. It offer treatment of pain, central nervous systems, metabolic disorders, and gastrointestinal disorders. The company was founded in 2015 and is headquartered in Seattle, WA.
8
| Holding Company | Pharmaceuticals: Major | 8 |
TVM Capital Corp.
 TVM Capital Corp. Investment ManagersFinance TVM Capital Corp (TVM Capital) is a venture capital subsidary of TVM Capital GmbH founded in 1986. The firm is headquartered in Boston, Massachusetts.
7
| Subsidiary | Investment Managers | 7 |
| Extinct | Pharmaceuticals: Major | 7 | |
TVM Capital GmbH
 TVM Capital GmbH Investment ManagersFinance TVM Capital GmbH (TVMC) is an international venture capital firm headquartered in Munich, Germany. Founded in 1983, the firm was formerly known as Techno Venture Management.
7
| Private Company | Investment Managers | 7 |
Implicit Bioscience Ltd.
 Implicit Bioscience Ltd. BiotechnologyHealth Technology Implicit Bioscience Ltd. operates as a clinical-stage immunotherapy drug development company. It develops drugs that modulate the host immune response to disease. The firm develops small molecule dipeptide oglufanide disodium for community and hospital-acquired infections including those caused by bio-threat agents. The company was founded by Garry Llewellyn Redlich, Peter Ronald Andrews and Ian Hector Frazer and is headquartered in Woolloongabba, Australia.
6
| Private Company | Biotechnology | 6 |
| Private Company | Financial Conglomerates | 5 | |
Apic Bio, Inc.
 Apic Bio, Inc. Packaged SoftwareTechnology Services Apic Bio, Inc. engages in the development of treatment for neurological and liver diseases. It offers THRIVE, a platform that silences a mutant gene product and replaces a normal gene product in a single dual function vector. The company was founded by Robert H. Brown, Jr., John Reilly, and Christian Mueller in 2017 and is headquartered in North Cambridge, MA.
4
| Holding Company | Packaged Software | 4 |
Skyline Management LLC
 Skyline Management LLC Investment ManagersFinance Skyline Management LLC (Skyline Management) is a venture capital firm founded in 1997 by John Gordon Freund. The firm is headquartered in Palo Alto, California.
3
| Private Company | Investment Managers | 3 |
| Extinct | Biotechnology | 3 | |
BYOMass, Inc.
 BYOMass, Inc. Miscellaneous Commercial ServicesCommercial Services BYOMass, Inc. provides investment holding services. The company is headquartered in Sudbury, MA.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Palleon Pharma, Inc.
 Palleon Pharma, Inc. BiotechnologyHealth Technology Palleon Pharma, Inc. operates as a biotechnology company. The company is headquartered in Cambridge, MA.
2
| Subsidiary | Biotechnology | 2 |
Somatogen, Inc.
 Somatogen, Inc. BiotechnologyHealth Technology Somatogen, Inc. develops specialty oxygen therapeutics. It is engaged in the research, clinical development and commercialization of genetically engineered recombinant human hemoglobin-based products. The company is located in Boulder, CO.
1
| Subsidiary | Biotechnology | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Stephen J. Hoffman
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Undergraduate Degree Masters Business Admin | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Private Equity Analyst | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Doctorate Degree Undergraduate Degree | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin Undergraduate Degree | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Investor Relations Contact Director/Board Member | |
Engage Therapeutics, Inc.
 Engage Therapeutics, Inc. BiotechnologyHealth Technology Engage Therapeutics, Inc. engages in the development of rescue therapy for uncontrolled epileptic seizures. The company was founded by Gregory T. Mayes III and Jouko Isojarvi in 2017 and is headquartered in Summit, NJ. | Biotechnology | Director/Board Member Director/Board Member Chief Operating Officer | |
| EDITAS MEDICINE, INC. | Biotechnology | Director of Finance/CFO Chief Executive Officer Chief Executive Officer | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Union College (New York) | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Founder Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| FORMA THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member President | |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Investment Managers | Founder Private Equity Investor Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Corporate Officer/Principal Founder | |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Founder Corporate Officer/Principal Corporate Officer/Principal | |
Tevard Biosciences, Inc.
 Tevard Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Tevard Biosciences, Inc. is a biotechnology company based in Cambridge, MA. Tevard Biosciences is focused on developing trna-based and other modulating therapies to cure a broad range of genetic diseases. The company is advancing the use of its novel suppressor trna, enhancer trna, and mrna amplifier platforms in neurological disorders, heart disease, and muscular dystrophies. The company was founded in 2017 by Warren Burt Lammert, Harvey F. Lodish, Daniel Fischer, and Jeffrey Coller. Daniel Fischer has been the CEO since 2017. | Miscellaneous Commercial Services | Director/Board Member Founder Director/Board Member | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | President President Chief Executive Officer | |
Warburg Pincus LLC
 Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Investment Managers | Investment Committee Member Private Equity Investor Private Equity Investor | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| ALZA CORPORATION | Pharmaceuticals: Major | President Chief Tech/Sci/R&D Officer General Counsel | |
| Boston University | College/University | Graduate Degree Undergraduate Degree Masters Business Admin | |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Chief Operating Officer Corporate Officer/Principal Director/Board Member | |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| VERASTEM, INC. | Biotechnology | Director of Finance/CFO Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Palleon Pharmaceuticals, Inc.
 Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Founder Director/Board Member | |
EdenRoc Sciences LLC
 EdenRoc Sciences LLC BiotechnologyHealth Technology EdenRoc Sciences LLC engages in the business of biotechnology. The company was founded in 2016 and is headquartered in Birmingham, MI. | Biotechnology | Director/Board Member Founder | |
Areteia Therapeutics, Inc.
 Areteia Therapeutics, Inc. BiotechnologyHealth Technology Areteia Therapeutics, Inc. is a clinical stage biotechnology company that focuses on developing and delivering novel inflammation and immunology therapies for respiratory patients. The company is based in Short Hills, NJ, and the CEO of the company is Jorge Bartolome. The company's initial focus is on developing the first potential oral drug for eosinophilic asthma, with its lead drug candidate being dexpramipexole, a first-in-class oral eosinophil maturation inhibitor. Areteia was created by Population Health Partners and Knopp Biosciences, and a syndicate of leading life sciences and strategic investors has committed to investing up to $350 million in series A financing to establish Areteia and advance dexpramipexole through phase III clinical trials. | Biotechnology | Director/Board Member Director/Board Member | |
| XENOPORT, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
Life Biosciences, Inc.
 Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA. | Electronic Equipment/Instruments | Founder Founder | |
| University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree | |
Spoke Sciences, Inc.
 Spoke Sciences, Inc. Information Technology ServicesTechnology Services Spoke Sciences, Inc. is an ingredient technology company that develops innovative approaches to provide better, safer, and more reliable functional ingredients to foods, beverages, and cosmetics. The company is based in Bainbridge Island, WA. The company's team of pharmaceutical and consumer products industry veterans bridges the best ideas from pharma and applies them in novel ways to improved consumer goods. Spoke Sciences has been developing a portfolio of groundbreaking technology to solve solubility needs and is advancing patented technologies developed in pharma and applying those to innovative consumer products. Gregory F Wesner has been the CEO of the company since 2021. | Information Technology Services | Chief Executive Officer Director/Board Member | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Doctorate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Graduate Degree | |
Immetas Therapeutics, Inc.
 Immetas Therapeutics, Inc. BiotechnologyHealth Technology Immetas Therapeutics, Inc. develops novel therapeutics that modulates the innate immune system to treat age-related cancers and inflammatory diseases. The company was founded by J. Gene Wang and David A. Sinclair in October 2018 and is headquartered in East Hanover, NJ. | Biotechnology | Founder Founder | |
Arc Bio LLC
 Arc Bio LLC BiotechnologyHealth Technology Arc Bio LLC is an American company that is revolutionizing microbial detection by providing turnkey metagenomics solutions that combine a next-generation sequencing laboratory workflow with an automated bioinformatics pipeline. Arc Bio is based in an undisclosed location. The private company's Galileo™ platform empowers researchers and laboratorians to transition into the next era of infectious disease detection through an integrated set of easy-to-use, actionable genomics tools. The company aims to create a healthier world by delivering robust sample-to-report microbial profiling workflows combined with data-driven health intelligence software tools to enable a new standard of care for disease detection and monitoring. The company was founded by David Andrew Sinclair, Todd Dickinson, David Sinclair, and Carlos Bustamante. Todd Dickinson has been the CEO since incorporation. | Biotechnology | Founder Founder | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
Hydra Biosciences, Inc.
 Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 49 |
| Vereinigtes Königreich | 2 |
| Schweiz | 2 |
Sektoral
| Health Technology | 24 |
| Consumer Services | 18 |
| Commercial Services | 5 |
| Finance | 5 |
| Electronic Technology | 2 |
Operativ
| Director/Board Member | 638 |
| Corporate Officer/Principal | 190 |
| Independent Dir/Board Member | 176 |
| Director of Finance/CFO | 136 |
| Founder | 96 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Daniel Geffken | 53 |
| Jonathan Leff | 45 |
| Mark Wan | 44 |
| Kevin Bitterman | 36 |
| Brian Halak | 36 |
| Peter Kolchinsky | 32 |
| Christoph H. Westphal | 32 |
| Paul Schimmel | 31 |
| Paul Berns | 28 |
| David Sinclair | 27 |
| Jens Eckstein | 27 |
| Guy Nohra | 27 |
| J. Buchi | 26 |
| Howard Rosen | 26 |
| Adam Koppel | 26 |
- Börse
- Insiders
- Stephen J. Hoffman
- Unternehmensverbindungen
